|
ARHGAP11B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42239999965244E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.096200E-03 |
| Normal-vs-Stage2 |
1.181230E-01 |
| Normal-vs-Stage3 |
7.951400E-04 |
| Normal-vs-Stage4 |
4.453600E-02 |
| Stage1-vs-Stage2 |
5.382200E-01 |
| Stage1-vs-Stage3 |
1.511750E-02 |
| Stage1-vs-Stage4 |
1.391620E-01 |
| Stage2-vs-Stage3 |
3.024600E-01 |
| Stage2-vs-Stage4 |
2.421600E-01 |
| Stage3-vs-Stage4 |
5.835600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37790000001681E-06 |
| Normal-vs-AfricanAmerican |
2.116300E-03 |
| Normal-vs-Asian |
1.989240E-01 |
| Caucasian-vs-AfricanAmerican |
8.642000E-01 |
| Caucasian-vs-Asian |
4.995200E-01 |
| AfricanAmerican-vs-Asian |
5.514000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.211500E-04 |
| Normal-vs-Female |
4.05650000001589E-06 |
| Male-vs-Female |
1.002820E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.758500E-03 |
| Normal-vs-Extreme_Weight |
2.462100E-02 |
| Normal-vs-Obese |
1.184780E-04 |
| Normal-vs-Extreme_Obese |
7.341000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.119810E-01 |
| Normal_Weight-vs-Obese |
6.090200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.478400E-02 |
| Extreme_Weight-vs-Obese |
8.635700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.061600E-01 |
| Obese-vs-Extreme_Obese |
5.937800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.180200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.49059999998702E-06 |
| Normal-vs-Age(61-80Yrs) |
1.482230E-03 |
| Normal-vs-Age(81-100Yrs) |
2.342800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.573800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.577500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.508100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.337200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.107800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.193400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.218600E-03 |
| Normal-VS-Type2 PRCC |
1.578770E-04 |
| Normal-VS-KIRP CIMP |
2.621700E-03 |
| Normal-VS-Unclassified PRCC |
6.026400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.558000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.261600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.410330E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.017520E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.667000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.311600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.297200E-03 |
| Normal-vs-N1 |
8.07409999999953E-05 |
| Normal-vs-N2 |
2.683400E-01 |
| N0-vs-N1 |
5.655400E-03 |
| N0-vs-N2 |
4.084200E-01 |
| N1-vs-N2 |
8.614800E-01 |
|
|
